609781-33-1 Usage
Uses
Used in Pharmaceutical Research and Development:
tert-Butyl 4-(4-carbamoylphenoxy)piperidine-1-carboxylate is used as a building block for the synthesis of various pharmacologically relevant compounds due to its unique structure and properties. It contributes to the development of new drugs and bioactive molecules, enhancing the therapeutic potential of pharmaceutical formulations.
Used in Drug Synthesis:
In the pharmaceutical industry, tert-Butyl 4-(4-carbamoylphenoxy)piperidine-1-carboxylate is used as a key intermediate in the synthesis of drugs, particularly those targeting central nervous system disorders, cardiovascular diseases, and other therapeutic areas. Its presence in the molecular structure can influence the pharmacokinetics, pharmacodynamics, and overall efficacy of the resulting drug molecules.
Used in Bioactive Molecule Synthesis:
tert-Butyl 4-(4-carbamoylphenoxy)piperidine-1-carboxylate is employed as a precursor in the synthesis of bioactive molecules, which can be further modified or functionalized to exhibit specific biological activities. This allows researchers to explore novel therapeutic agents with improved potency, selectivity, and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 609781-33-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,9,7,8 and 1 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 609781-33:
(8*6)+(7*0)+(6*9)+(5*7)+(4*8)+(3*1)+(2*3)+(1*3)=181
181 % 10 = 1
So 609781-33-1 is a valid CAS Registry Number.
609781-33-1Relevant academic research and scientific papers
OPIOID RECEPTOR ANTAGONISTS
-
Page/Page column 46, (2010/02/12)
A compound of the formula (I) wherein the variables X1 to X5, R1 to R7 including R3', E, q, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, dia
BENZAMIDE DERIVATIVES
-
Page 24, (2010/02/10)
A compound represented by formula (1): wherein X is a single bond or a substituted or unsubstituted lower alkylene group; Z is a saturated or unsaturated monocyclic hydrocarbon ring group or the like; and each of R1, R2, R3 and R4, which may be the same or different, is a hydrogen atom, a halogen atom, a nitro group, a cyano group, a carboxyl group, a substituted or unsubstituted alkyl group, or the like, a prodrug of said compound, or a pharmaceutically acceptable salt of said compound or prodrug has inhibitory effect on Rho kinase and hence is useful for treating diseases which are such that morbidity due to them is expected to be improved by inhibition of Rho kinase and secondary effects such as inhibition of the Na+/H+ exchange transport system caused by the Rho kinase inhibition, for example, hypertension.
